Davis Blaine
CIK 0001802188
Chief Financial Officer
Filings
7
Latest Jan 8, 2026
Issuers covered
2
Showing
7 of 7
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 33% | -5.7% | -9.8% | +10.8% | -18.0% |
| 90 days | 3 | 100% | +26.9% | +26.8% | +42.7% | +11.4% |
| 180 days | 2 | 100% | +35.7% | +35.7% | +38.9% | +32.5% |
| 365 days | 2 | 100% | +59.5% | +59.5% | +60.1% | +59.0% |
Issuers
Companies where Davis Blaine has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | 6 | Jan 8, 2026 |
| TARA | Protara Therapeutics, Inc. | 1 | Jan 5, 2022 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|